IM Cannabis Corp. cash flow statement
In fiscal 2025, IM Cannabis Corp.'s operations generated $3.4m of cash; it spent $9,307 on capital projects, leaving free cash flow of $3.4m.
Cash flow statement
| Fiscal year | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 |
|---|---|---|---|---|---|---|---|
| Cash from operations | −4 | −6 | −27 | −10 | −6 | −1 | 3 |
| Depreciation and amortisation | 0 | 1 | 2 | 2 | — | — | — |
| Stock-based pay | 2 | 3 | 6 | 3 | 0 | 0 | 0 |
| Capital spending | 1 | 2 | 4 | 1 | 0 | 0 | 0 |
| Free cash flow | −6 | −8 | −31 | −11 | −6 | −1 | 3 |
| Free cash flow after stock pay | −8 | −10 | −37 | −14 | −7 | −1 | 3 |
Compare with peers
- Cumberland Pharmaceuticals Inc cash flow
- BGM Group Ltd. cash flow
- Sunshine Biopharma Inc. cash flow
- Biofrontera Inc. cash flow
- Scilex Holding Co cash flow
Head to head: CPIX vs IMCCBGM vs IMCCIMCC vs SBFMBFRI vs IMCC
More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies